Selasa, 03 Juli 2012

Stopping Diabetes In Mice

Stopping Diabetes In Mice

Editor's Choice
Main Category: Diabetes
Also Included In: Stem Cell Research
Article Date: 03 Jul 2012 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article Advertisement


Patient / Public:not yet rated

Healthcare Prof:not yet rated


According to a study published in the scientific journal Diabetes, Swedish researchers from the Karolinska Institutet managed to prevent onset of Type 1 diabetes in mice genetically susceptible to the disease by injecting them with specifically prepared cells that prevented insulin-producing pancreatic beta cells from continuously being destroyed before clinical diabetes occurs.

In Type 1 diabetes, the body's immune system attacks and kills insulin-producing beta cells, leading to an insulin deficiency that needs to be rectified by injecting insulin. Although scientists do not know the initial causes of this autoimmune destruction, they have discovered that macrophages, a specific type of immune cells, play an active role in killing pancreatic beta cells in patients with Type 1 diabetes. However, according to previous studies, macrophages can also protect against inflammation-mediated tissue damage. Immune cells use cytokines (signal molecules) for signaling each other with instructions on how the cells should act.

The researchers set out to determine which cytokines are necessary to instruct macrophages to become protective cells.

"We managed to achieve this aim, defining a novel combination of cytokines that confer on macrophages the ability to protect mice from developing Type 1 diabetes. It has never previously been reported, that such an adoptive transfer cell therapy can be used in Type 1 diabetes and this study could thus represent a major advance towards disease prevention."



For their study, the team used 'NOD mice', i.e. mice that are genetically susceptible to spontaneously develop Type 1 diabetes between the ages of 12 to 30 weeks to grow macrophages from the mice' bone marrow progenitors. They then stimulated the mature macrophages with the defined combination of cytokines. When the NOD mice reached the age of 16 weeks, the researchers divided them into three separate groups; mice treated with cytokine-stimulated macrophages treatment, mice treated with untreated macrophages and untreated animals. 



The animals were monitored for a duration of 12 weeks after treatment, and the team was able to visualize the extent of the beta cells' immune-mediated attack in each treatment group by using a specific three-dimensional imaging technique that was developed at Umeå University, Sweden.

The results revealed that at the end of the follow-up period, only 25% of mice in the cytokine-treated macrophages group had developed Type 1 diabetes compared with 83% of the animals in the control groups, which developed the disease. 


Dr. Harris concludes: "The cell therapy was initiated just 2 weeks before mice developed clinical diabetes. At this stage few insulin-producing beta cells remain in the pancreas, yet we were able to protect these so that the mice never developed diabetes. Such a successful late-stage intervention has never previously been reported and is a significant result of our study. At the time of their clinical Type 1 diabetes diagnosis, most human individuals have already lost most of their insulin-producing beta cells." 



Written By Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

"Diabetes Reversed in Mice Using Stem Cells"
Alireza Rezania, Jennifer E. Bruin, Michael J. Riedel, Majid Mojibian, Ali Asadi, Jean Xu, Rebecca Gauvin, Kavitha Narayan, Francis Karanu, John J. O’Neil, Ziliang Ao, Garth L. Warnock and Timothy J. Kieffer
Diabetes, June 2012, doi: 10.2337/db11-1711 Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.


Advertisement

Add Your Opinion On This Article

'Stopping Diabetes In Mice - Researchers Make Major Breakthrough'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar